Japan Approves Roche/Chugai’s Tumor-Agnostic Rozlytrek, Alnylam’s RNAi Drug and More

June 19, 2019
The Ministry of Health, Labor and Welfare (MHLW) approved a throng of new medicines on June 18, with Japan becoming the first country to give the green light to Roche/Chugai Pharmaceutical’s tumor-agnostic agent entrectinib, which now carries the brand name...read more